Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
US10189858B2 · kind B2 · utility
3Cited by
0References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 13, 2017 |
| Grant date | Jan 29, 2019 |
| Priority date | — |
| Expiry date | Oct 13, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B59/002
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides deuterium-enriched isoindolinonyl-piperidinonyl conjugates, deuterium-enriched oxoquinazolin-3(4H)-yl-piperidinonyl conjugates, pharmaceutical compositions, and methods of using such conjugates and pharmaceutical compositions to treat cancer, angiogenesis disorders, immune disorders, and other medical disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.